Drug Trial Radar · NCT04808505
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Jul 18, 2023
Primary completion
Jul 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Amicus TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in ERT-experienced and ERT-naïve pediatric subjects with IOPD.
Conditions
- Glycogen Storage Disease Type II Infantile Onset
Interventions
Cipaglucosidase alfaBiological
Sterile lyophilized powder intravenous (IV) infusion
MiglustatDrug
65 mg oral capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects with infusion-associated reactions (IARs)Time frame: 104 weeks
Locations
14 sites in 6 countries. Site status is shown where the registry gives one.
University of Florida Clinical Research Center
Gainesville, Florida · Recruiting
The Emory Clinic
Atlanta, Georgia · Recruiting
Duke University Early Phase Research Unit
Durham, North Carolina · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
UPMC Hospital of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
University of Utah, Clinical and Translational Sciences Institute
Salt Lake City, Utah · Recruiting
Universitätsklinikum Gießen und Marburg GmbH, Zentrum fur Kinderheilkunde und Jugendmedizin Abteilung fur Kinderneurologic, Sozialpadiatric und Epileptologie
Giessen, Germany · Recruiting
Universitätsklinikum Heidelberg - Pädiatrisches Klinisch-Pharmakologisches Studienzentrum (paedKliPS)
Heidelberg, Germany · Recruiting
SphinCS GmbH
Höchheim, Germany · Recruiting
Universitätsklinikum Münster Klinik für Kinder- und Jugendmedizin Albert-Schweitzer-Campus 1
Münster, Germany · Recruiting
AOU Federico II
Naples, Italy · Recruiting
Erasmus MC, Sophia Kinderziekenhuis
Rotterdam, Netherlands · Recruiting
National Taiwan University Hospital
Taipei, Taiwan · Withdrawn
Great Ormond Street Hospital for Children NHS Foundation Trust
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.